Neurocrine Biosciences, Inc. (NBIX)

128.13 -1.51 (-1.16%) USD  |  NASDAQ  |  Mar 06, 16:00
128.18 +0.05 (+0.04%) Pre-Market: 20:00
More

Neurocrine Biosciences Net Debt Issuance (3 Year Growth)

Net Debt Issuance (3 Year Growth) Chart

View Net Debt Issuance (3 Year Growth) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Debt Issuance (3 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Debt Issuance (3 Year Growth) Range, Past 5 Years

View Net Debt Issuance (3 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Debt Issuance (3 Year Growth) Benchmarks

View Net Debt Issuance (3 Year Growth) Benchmarks
Start Trial
Glaukos Corp. --
Edgewise Therapeutics, Inc. --
Nuvalent, Inc. --
Marker Therapeutics, Inc. --
CapsoVision, Inc. --